GFAPdelta/GFAPalpha ratio directs astrocytoma gene expression towards a more malignant profile.

[en] Astrocytomas are the most common malignant brain tumours and are to date incurable. It is unclear how astrocytomas progress into higher malignant grades. The intermediate filament cytoskeleton is emerging as an important regulator of malignancy in several tumours. The majority of the astrocytomas express the intermediate filament protein Glial Fibrillary Acidic Protein (GFAP). Several GFAP splice variants have been identified and the main variants expressed in human astrocytoma are the GFAPalpha and GFAPdelta isoforms. Here we show a significant downregulation of GFAPalpha in grade IV astrocytoma compared to grade II and III, resulting in an increased GFAPdelta/alpha ratio. Mimicking this increase in GFAPdelta/alpha ratio in astrocytoma cell lines and comparing the subsequent transcriptomic changes with the changes in the patient tumours, we have identified a set of GFAPdelta/alpha ratio-regulated high-malignant and low-malignant genes. These genes are involved in cell proliferation and protein phosphorylation, and their expression correlated with patient survival. We additionally show that changing the ratio of GFAPdelta/alpha, by targeting GFAP expression, affected expression of high-malignant genes. Our data imply that regulating GFAP expression and splicing are novel therapeutic targets that need to be considered as a treatment for astrocytoma.

Disciplines :

Genetics & genetic processes

Author, co-author :

Stassen, Oscar M. J. A.

van Bodegraven, Emma J.

Giuliani, Fabrizio

Moeton, Martina

Kanski, Regina

Sluijs, Jacqueline A.

van Strien, Miriam E.

Kamphuis, Willem

Robe, Pierre ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques

Hol, Elly M.

Language :

English

Title :

GFAPdelta/GFAPalpha ratio directs astrocytoma gene expression towards a more malignant profile.

Publication date :

2017

Journal title :

Oncotarget

eISSN :

1949-2553

Publisher :

Impact Journals, United States - New York

Volume :

Issue :

Pages :

88104-88121

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 08 February 2018

Statistics

Number of views

87 (1 by ULiège)

Number of downloads

16 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O; Dutch Society for Neuro-Oncology. Changing incidence and improved survival of gliomas. Eur J Cancer. 2014; 50:2309-2318. https://doi.org/10.1016/j. ejca.2014.05.019
Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell. 2012; 149:36-47. https://doi.org/10.1016/j.cell.2012.03.009
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114:97-109. https://doi.org/10.1007/ s00401-007-0243-4
Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res. 2013; 19:764-772. https://doi.org/10.1158/1078-0432.CCR-12-3002
Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suvà ML, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014; 344:1396-1401. https://doi.org/10.1126/science.1254257
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17:98-110. https://doi.org/10.1016/j.ccr.2009.12.020
Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015; 372:2481-2498. https://doi.org/10.1056/ NEJMoa1402121
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 2012; 60:502-514. https://doi.org/10.1002/glia.21264
Coulombe PA, Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol. 2004; 6:699-706. https://doi.org/10.1038/ ncb0804-699
Yang J, Dominguez B, de Winter F, Gould TW, Eriksson JE, Lee KF. Nestin negatively regulates postsynaptic differentiation of the neuromuscular synapse. Nat Neurosci. 2011; 14:324-330. https://doi.org/10.1038/nn.2747
Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013; 155:1639-1651. https://doi. org/10.1016/j.cell.2013.11.029
Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick SL. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Mol Cell Biol. 2013; 33:4448-4460. https://doi.org/10.1128/MCB.00241-13
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell. 2009; 139:871-890. https://doi.org/10.1016/j. cell.2009.11.007
Mendez MG, Kojima SI, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010; 24:1838-1851. https://doi.org/10.1096/fj.09-151639
Virtakoivu R, Mai A, Mattila E, De Franceschi N, Imanishi SY, Corthals G, Kaukonen R, Saari M, Cheng F, Torvaldson E, Kosma VM, Mannermaa A, Muharram G, et al. Vimentin-ERK signaling uncouples Slug gene regulatory function. Cancer Res. 2015; 75:2349-2369. https://doi. org/10.1158/0008-5472.CAN-14-2842
Havel LS, Kline ER, Salgueiro AM, Marcus AI. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene. 2015; 34:1979-1990. https://doi.org/10.1038/ onc.2014.123
Velasco ME, Dahl D, Roessmann U, Gambetti P. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer. 1980; 45:484-494. https://doi.org/10.1002/1097-0142(19800201)45:3<484::AIDCNCR2820450312> 3.0.CO;2-9
Skalli O, Wilhelmsson U, örndahl C, Fekete B, Malmgren K, Rydenhag B, Pekny M. Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins. Hum Pathol. 2013; 44:2081-2088. https://doi.org/10.1016/j. humpath.2013.03.013
Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol. 2011; 93:421-443. https://doi.org/10.1016/j. pneurobio.2011.01.005
Kamphuis W, Middeldorp J, Kooijman L, Sluijs JA, Kooi EJ, Moeton M, Freriks M, Mizee MR, Hol EM. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiol Aging. 2014; 35:492-510. https://doi.org/10.1016/j. neurobiolaging.2013.09.035
Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC. Enhanced glial fibrillary acidic protein-d expression in human astrocytic tumor. Neurosci Lett. 2009; 463:182-187. https://doi.org/10.1016/j.neulet.2009.07.076
Heo DH, Kim SH, Yang KM, Cho YJ, Kim KN, Yoon DH, Kang TC. A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-d. J Neurooncol. 2012; 108:45-52. https:// doi.org/10.1007/s11060-012-0801-z
Brehar FM, Arsene D, Brinduse LA, Gorgan MR. Immunohistochemical analysis of GFAP-d and nestin in cerebral astrocytomas. Brain Tumor Pathol. 2015; 32:90-98. https://doi.org/10.1007/s10014-014-0199-8
Moeton M, Stassen OM, Sluijs JA, van der Meer VW, Kluivers LJ, van Hoorn H, Schmidt T, Reits EA, van Strien ME, Hol EM. GFAP isoforms control intermediate filament network dynamics, cell morphology, and focal adhesions. Cell Mol Life Sci. 2016; 73:4101-4120. https:// doi.org/10.1007/s00018-016-2239-5
Moeton M, Kanski R, Stassen OM, Sluijs JA, Geerts D, van Tijn P, Wiche G, van Strien ME, Hol EM. Silencing GFAP isoforms in astrocytoma cells disturbs laminin-dependent motility and cell adhesion. FASEB J. 2014; 28:2942-2954. https://doi.org/10.1096/fj.13-245837
Middeldorp J, Kamphuis W, Sluijs JA, Achoui D, Leenaars CH, Feenstra MG, van Tijn P, Fischer DF, Berkers C, Ovaa H, Quinlan RA, Hol EM. Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J. 2009; 23:2710-2726. https://doi. org/10.1096/fj.08-127696
Perng MD, Wen SF, Gibbon T, Middeldorp J, Sluijs J, Hol EM, Quinlan RA. Glial fibrillary acidic protein filaments can tolerate the incorporation of assemblycompromised GFAP-delta, but with consequences for filament organization and B-Crystallin association. Mol Biol Cell. 2008; 19:4521-4533. https://doi.org/10.1091/ mbc.E08-03-0284
van Strien ME, Sluijs JA, Reynolds BA, Steindler DA, Aronica E, Hol EM. Isolation of neural progenitor cells from the human adult subventricular zone based on expression of the cell surface marker CD271. Stem Cells Transl Med. 2014; 3:470-480. https://doi.org/10.5966/ sctm.2013-0038
Roelofs RF, Fischer DF, Houtman SH, Sluijs JA, Van Haren W, Van Leeuwen FW, Hol EM. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia. 2005; 52:289-300. https://doi.org/10.1002/glia.20243
Nielsen AL, Holm IE, Johansen M, Bonven B, Jørgensen P, Jørgensen AL. A new splice variant of glial fibrillary acidic protein, GFAPe, interacts with the presenilin proteins. J Biol Chem. 2002; 277:29983-29991. https://doi.org/10.1074/jbc. M112121200
Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007; 313:2050-2062. https://doi.org/10.1016/j. yexcr.2007.03.040
Leduc C, Etienne-Manneville S. Intermediate filaments in cell migration and invasion: the unusual suspects. Curr Opin Cell Biol. 2015; 32:102-112. https://doi.org/10.1016/j. ceb.2015.01.005
Wilhelmsson U, Eliasson C, Bjerkvig R, Pekny M. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression. Oncogene. 2003; 22:3407-3411. https://doi.org/10.1038/ sj.onc.1206372
Liu JK, Lubelski D, Schonberg DL, Wu Q, Hale JS, Flavahan WA, Mulkearns-Hubert EE, Man J, Hjelmeland AB, Yu J, Lathia JD, Rich JN. Phage display discovery of novel molecular targets in glioblastoma-initiating cells. Cell Death Differ. 2014; 21:1325-1339. https://doi.org/10.1038/ cdd.2014.65
Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, Ennis M, McDonough WS, Berens ME, Symons M, Rutka JT. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol. 2008; 173:1828-1838. https://doi.org/10.2353/ ajpath.2008.080043
Ellie E, Loiseau H, Lafond F, Arsaut J, Demotes-Mainard J. Differential expression of inducible nitric oxide synthase mRNA in human brain tumours. Neuroreport. 1995; 7:294-296
Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol. 2004; 108:43-48. https:// doi.org/10.1007/s00401-004-0860-0
Hara E, Takahashi K, Tominaga T, Kumabe T, Kayama T, Suzuki H, Fujita H, Yoshimoto T, Shirato K, Shibahara S. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem Biophys Res Commun. 1996; 224:153-158. https://doi.org/10.1006/ bbrc.1996.0999
Lin YM, Jan HJ, Lee CC, Tao HY, Shih YL, Wei HW, Lee HM. Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism. Eur J Pharmacol. 2008; 593:1-9. https://doi.org/10.1016/j. ejphar.2008.06.111
Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Oncotarget. 2015; 6:41383-41397. https://doi. org/10.18632/oncotarget.5510
Palani M, Arunkumar R, Vanisree AJ. Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma. Neuromolecular Med. 2014; 16:529-539. https://doi.org/10.1007/s12017-014-8303-0
Souady J, Hülsewig M, Distler U, Haier J, Denz A, Pilarsky C, Senninger N, Dreisewerd K, Peter-Katalinic J, Müthing J. Differences in CD75s-and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues. Glycobiology. 2011; 21:584-594. https://doi.org/10.1093/glycob/cwq200
Ducray F, Idbaih A, de Reyniès A, Bièche I, Thillet J, Mokhtari K, Lair S, Marie Y, Paris S, Vidaud M, Hoang-Xuan K, Delattre O, Delattre JY, Sanson M. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer. 2008; 7:41. https://doi. org/10.1186/1476-4598-7-41
Assimakopoulou M, Kondyli M, Gatzounis G, Maraziotis T, Varakis J. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer. 2007; 7:202. https://doi.org/10.1186/1471-2407-7-202
Xiong J, Zhou LI, Lim Y, Yang M, Zhu YH, Li ZW, Fu DL, Zhou XF. Mature brain-derived neurotrophic factor and its receptor TrkB are upregulated in human glioma tissues. Oncol Lett. 2015; 10:223-227. https://doi.org/10.3892/ ol.2015.3181
Bredel M, Scholtens DM, Harsh GR, Bredel C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC, Tibshirani R, Sikic BI. A network model of a cooperative genetic landscape in brain tumors. JAMA. 2009; 302:261-275. https://doi.org/10.1001/jama.2009.997
Park AL, Lin HK, Yang Q, Sing CW, Fan M, Mapstone TB, Gross NL, Gumerlock MK, Martin MD, Rabb CH, Fung KM. Differential expression of type 2 3a/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system. Int J Clin Exp Pathol. 2010; 3:743-754
Milde-Langosch K, Karn T, Schmidt M, zu Eulenburg C, Oliveira-Ferrer L, Wirtz RM, Schumacher U, Witzel I, Schütze D, Müller V. Prognostic relevance of glycosylationassociated genes in breast cancer. Breast Cancer Res Treat. 2014; 145:295-305. https://doi.org/10.1007/ s10549-014-2949-z
Janke C, Ortiz J, Lechner J, Shevchenko A, Shevchenko A, Magiera MM, Schramm C, Schiebel E. The budding yeast proteins Spc24p and Spc25p interact with Ndc80p and Nuf2p at the kinetochore and are important for kinetochore clustering and checkpoint control. EMBO J. 2001; 20:777-791. https://doi.org/10.1093/emboj/20.4.777
Erhardt JA, Hynicka W, DiBenedetto A, Shen N, Stone N, Paulson H, Pittman RN. A novel F box protein, NFB42, is highly enriched in neurons and induces growth arrest. J Biol Chem. 1998; 273:35222-35227
Wen H, Kim N, Fuentes EJ, Mallinger A, Gonzalez-Alegre P, Glenn KA. FBG1 is a promiscuous ubiquitin ligase that sequesters APC2 and causes S-phase arrest. Cell Cycle. 2010; 9:4506-4517. https://doi.org/10.4161/cc.9.22.13743
Eyler CE, Wu Q, Yan K, MacSwords JM, Chandler-Militello D, Misuraca KL, Lathia JD, Forrester MT, Lee J, Stamler JS, Goldman SA, Bredel M, McLendon RE, et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 2011; 146:53-66. https://doi.org/10.1016/j.cell.2011.06.006
Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, Geber A, Fligelman B, Leversha M, Brennan C, Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010; 468:829-833. https://doi. org/10.1038/nature09624
Yoshida Y, Chiba T, Tokunaga F, Kawasaki H, Iwai K, Suzuki T, Ito Y, Matsuoka K, Yoshida M, Tanaka K, Tai T. E3 ubiquitin ligase that recognizes sugar chains. Nature. 2002; 418:438-442. https://doi.org/10.1038/nature00890
Glavey SV, Manier S, Natoni A, Sacco A, Moschetta M, Reagan MR, Murillo LS, Sahin I, Wu P, Mishima Y, Zhang Y, Zhang W, Zhang Y. The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma. Blood. 2014; 124:1765-1776. https://doi.org/10.1182/ blood-2014-03-560862
Leube RE, Moch M, Windoffer R. Intermediate filaments and the regulation of focal adhesion. Curr Opin Cell Biol. 2015; 32:13-20. https://doi.org/10.1016/j.ceb.2014.09.011
Kwiatkowska A, Didier S, Fortin S, Chuang Y, White T, Berens ME, Rushing E, Eschbacher J, Tran NL, Chan A, Symons M. The small GTPase RhoG mediates glioblastoma cell invasion. Mol Cancer. 2012; 11:65. https://doi. org/10.1186/1476-4598-11-65
Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol. 1999; 19:7870-7885
Al-Mutairi MS, Cadalbert LC, McGachy HA, Shweash M, Schroeder J, Kurnik M, Sloss CM, Bryant CE, Alexander J, Plevin R. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog. 2010; 6:e1001192. https://doi.org/10.1371/journal. ppat.1001192
Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, Rodríguez JJ, Orre M, Hol EM. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One. 2012; 7:e42823. https://doi. org/10.1371/journal.pone.0042823
Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain J Neurol. 2010; 133:3699-3723. https://doi.org/10.1093/brain/ awq258
Orre M, Kamphuis W, Osborn LM, Melief J, Kooijman L, Huitinga I, Klooster J, Bossers K, Hol EM. Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol Aging. 2014; 35:1-14. https://doi.org/10.1016/j. neurobiolaging.2013.07.008
Bossers K, Ylstra B, Brakenhoff RH, Smeets SJ, Verhaagen J, van de Wiel MA. Intensity-based analysis of dualcolor gene expression data as an alternative to ratio-based analysis to enhance reproducibility. BMC Genomics. 2010; 11:112. https://doi.org/10.1186/1471-2164-11-112
Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004. https://doi. org/10.2202/1544-6115.1027
Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 2015; 43:D1049-D1056. https://doi.org/10.1093/nar/gku1179
Alexa A, Rahnenführer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006; 22:1600-1607. https://doi.org/10.1093/bioinformatics/ btl140